Has Sofy Sendoya, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,089 in general payments to Sofy Sendoya, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sofy Sendoya, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sofy Sendoya, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sofy Sendoya, MD

Hospitalist · Apopka, FLNPI 1265660880

Payments from drug & device makers

$2,089in general payments, 2019–2025

Across 33 payments — averaging $63.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$488
AstraZeneca$324
Novartis$243
La Jolla Pharmaceutical Company$222
Pfizer$211
Gilead$196
plus $404 from 3 others

What the payments were for

Food & beverage$2,089100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	7	$488
AstraZeneca(2 entities)	3	$324
Novartis	6	$243
La Jolla Pharmaceutical Company	2	$222
Pfizer	6	$211
Gilead	3	$196
GSK	3	$155
Philips North America LLC	2	$136
Fisher Scientific Company L.L.C.	1	$113

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,089 in reported general payments places this provider in the 90th percentile of 1,570 hospitalist providers in Florida.

See all hospitalist providers in Florida →

Medicare billing

Part B allowed, 2024

$58,486

Medicare patients

170

Services billed

543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	11	$418
Cefdinir	14	$134
Atorvastatin Calcium	16	$119
Prednisone	13	$57
Oxycodone Hcl	14	$53

Paid to pharmacies, not to this prescriber.

Other hospitalist in Apopka

Mayra AbreuApopka$33K
Diego MunozApopka$17K
Gerald BahrApopka$4K
Sandi ColemanMiami$2.6M
Miguel Mujica BaellaMiami$1.8M
Fernando PedrazaMiami$1.8M
Jose PineroMiami$1.1M
Jose NegrinHomestead$674K
Fernando Piedra ChavezMiami$554K
Felipe Gascon-RodonPembroke Pines$441K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →